{"brief_title": "Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)", "brief_summary": "The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.", "condition": "Lipid Metabolism, Inborn Errors", "intervention_type": "Drug", "intervention_name": "Comparator: ezetimibe", "description": "Ezetimibe (MK0653) 10 mg once daily for 3 years.", "arm_group_label": "1", "criteria": "Inclusion Criteria: - Homozygous familial hypercholesterolemia or sitosterolemia Exclusion Criteria: - Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study", "gender": "All", "minimum_age": "8 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00092833.xml"}